Overview
- Description
The company is developing NeuroClues, an advanced eye-tracking-based diagnostic solution to enable earlier detection and prognosis of neurological disorders such as Parkinson’s, Alzheimer’s and multiple sclerosis.
- Website
- Country
- Belgium
- Sector
- Medical Technologies
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.